Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Sio Capital Management, LLC
Form 13F · Q2 2026

Sio Capital Management, LLC

CIK 1482416申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$6.0亿
申報組合市值
59
持倉數量
12
Quarters on record
Top 50
持倉數量

Sio Capital Management, LLC——持倉

共 59 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1AVR Anteris Technologies Global5.5M+3.0%$5463万9.0%
2COR Cencora Inc173,588+72.0%$4912万8.1%
3MMS Maximus Inc715,267−7.0%$3845万6.4%
4ALLO Allogene Therapeutics Inc13.3M—$2771万4.6%
5GMED Globus Med Inc301,816—$2385万3.9%
6GSK Gsk Plc436,700+13.2%$2289万3.8%
7TYRA Tyra Biosciences Inc695,315+14.8%$2221万3.7%
8WAY Waystar Hldg Corp925,834−43.6%$1901万3.1%
9IDYA Ideaya Biosciences Inc480,383—$1790万3.0%
10ORKA Oruka Therapeutics Inc177,118+33.7%$1686万2.8%
11CI The Cigna Group57,750—$1592万2.6%
12SNY Sanofi Sa364,200+52.0%$1554万2.6%
13ICLR Icon Pub Ltd Co88,186−71.2%$1532万2.5%
14VTRS Viatris Inc954,299—$1515万2.5%
15CROSS CTRY HEALTHCARE INC Cross Ctry Healthcare Inc1.1M+0.0%$1451万2.4%
16RAPP Rapport Therapeutics Inc307,657−16.1%$1282万2.1%
17ABT Abbott Laboratories128,656−31.0%$1167万1.9%
18CELC Celcuity Inc110,022−43.2%$1151万1.9%
19ZBH Zimmer Biomet Holdings Inc131,445+109.9%$1132万1.9%
20REGN Regeneron Pharmaceuticals18,000—$1122万1.9%
21BMY Bristol-Myers Squibb Co193,500—$1115万1.8%
22MDT Medtronic Plc142,500—$1115万1.8%
23VIR Vir Biotechnology Inc1.1M−28.2%$1096万1.8%
24SENS Senseonics Hldgs Inc1.6M+1275.6%$905万1.5%
25EYPT Eyepoint Inc623,130−13.7%$891万1.5%
26HELP Cybin Inc1.3M—$859万1.4%
27ANIP Ani Pharmaceuticals Inc97,305−63.4%$805万1.3%
28TARA Protara Therapeutics Inc1.9M−2.4%$734万1.2%
29RLMD Relmada Therapeutics Inc1.0M+4.0%$694万1.1%
30TNGX Tango Therapeutics Inc208,500—$652万1.1%
31AQST Aquestive Therapeutics Inc1.5M−22.7%$618万1.0%
32DNTH Dianthus Therapeutics Inc59,254−84.0%$578万1.0%
33SION Sionna Therapeutics Inc127,808−56.6%$562万0.9%
34OCUL Ocular Therapeutix Inc539,493−44.3%$530万0.9%
35ZBIO Zenas Biopharma Inc208,557−37.1%$529万0.9%
36DRUG Bright Minds Biosciences Inc73,952−14.1%$519万0.9%
37OKUR Onkure Therapeutics Inc1.1M+0.0%$492万0.8%
38SVRA Savara Inc617,675+0.6%$380万0.6%
39PMVP Pmv Pharmaceuticals Inc2.6M−14.4%$353万0.6%
40AVAH Aveanna Healthcare Hldgs Inc369,036—$316万0.5%
41OVID Ovid Therapeutics Inc1.0M−19.7%$270万0.4%
42IMNM Immunome Inc124,168−24.8%$263万0.4%
43ANTX An2 Therapeutics Inc529,933−19.4%$256万0.4%
44SER Serina Therapeutics Inc1.0M+0.0%$194万0.3%
45ALGS Aligos Therapeutics Inc327,237+0.0%$189万0.3%
46IBIO Ibio Inc904,268+0.0%$158万0.3%
47XLO Xilio Therapeutics Inc152,464+0.0%$146万0.2%
48AORT Artivion Inc48,481—$109万0.2%
49BBOT Bridgebio Oncology Therapeut130,628+0.0%$100万0.2%
50TELA Tela Bio Inc636,300+0.0%$48万0.1%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。